Kevin S. Boyle Sr., Chief Executive Officer at ZIOPHARM ONCOLOGY INC (ZIOP), bought 10,000 shares at $1.40 ($14K) on 2021-11-16, disclosed to the SEC on 2021-11-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.40 | 884 | $1K | 8.8% |
| 2 | $1.40 | 9,116 | $13K | 91.2% |
| Total | $1.40 avg | 10,000 | $14K | 100% |